Cristina Lucía Dávila-Fajardo

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent

Jesús Sánchez-Ramos, Cristina Lucía Dávila-Fajardo, Pablo Toledo Frías et al. · International Journal of Cardiology · 2016 · 63 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +11

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries

Kathrin Blagec, Jesse J. Swen, Rudolf Koopmann et al. · PLoS ONE · 2022 · 41 citations · Full text

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study

Cathelijne H. van der Wouden, Stefan Böhringer, Erika Cecchin et al. · Pharmacogenetics and Genomics · 2020 · 40 citations · Full text

Early Events in the Binding of the pPS10 Replication Protein RepA to Single Iteron and Operator DNA Sequences

Teresa Dı́az-López, Cristina Lucía Dávila-Fajardo, Franca Blaesing et al. · Journal of Molecular Biology · 2006 · 36 citations

Early Events, Single Iteron, Natural Sciences +10